A Performance Test Protocol for Closed System Transfer Devices Used During Pharmacy Compounding and Administration of Hazardous Drugs

September 2016
NIOSH Docket Number 288-A, CDC-2016-0090

NIOSH held a public meeting to discuss a universal closed system drug-transfer device (CSTD) testing (draft) protocol entitled, A Performance Test Protocol for Closed System Transfer Devices Used During Pharmacy Compounding and Administration of Hazardous Drugs. The new universal performance test protocol is applicable to both barrier and air-cleaning types of CSTDs. The meeting allowed commenters the opportunity to address the new draft protocol, the proposed list of hazardous drug test surrogates, and to discuss NIOSH questions regarding the new protocol. The meeting was open to the public, limited only by the capacity (80 attendees) of the conference room. The public meeting was held on November 7, 2016, 9:00 a.m. – 3:00 p.m. Eastern Time. It was held at CDC/NIOSH Alice Hamilton Laboratories Conference Room C, 5555 Ridge Avenue, Cincinnati, OH 45213. Registration was required for both in-person and LiveMeeting participation. Information on how to register was in the Federal Register notice along with information for any non-U.S. citizen who wished to attend this meeting.

To view the notice and related materials, visit http://www.regulations.govExternal and enter CDC-2016-0090 in the search field and click “Search.”

To view previous docket see CDC-2015-0075; NIOSH-288.

Reference Documents
Page last reviewed: March 1, 2018